People

A CFO’s Journey from Celestial to StarTek

Also, shocking news: consultant takes job as finance chief.
Lisa YoonAugust 29, 2001
  • When David Rosenthal was a kid, he must have wanted to be an astronaut.

    Meaning? Well, Rosenthal has just been named the new CFO at business- support services company StarTek Inc., replacing Dennis Swenson, who is retiring. Prior to coming on board at StarTek, he was chief financial officer at Boulder, Colo.-based Celestial Seasonings Inc.. At Celestial, Rosenthal oversaw the $390 million merger of the tea company with Hain Food Group. Before joining Celestial Seasonings, he was CFO of Hauser Inc.

    Denver-based StarTek counts Microsoft as one of the biggest customers. The software giant accounts for about about 70 percent of StarTek’s sales. StarTek management says it has plans to expand its client base beyond the high-tech sector and into the health care and financial services industries. StarTek also helps companies get into space: the company licenses Internet domain names through it owns Domain.com subsidiary.

    Rosenthal’s is the second new senior management appointment at StarTek since June. Earlier, William Meade Jr. was named CEO.

    The 7 Habits of Highly Effective CFOs

    The 7 Habits of Highly Effective CFOs

    Download our whitepaper to discover the technical and behavioral skills needed to lead your business forward.

    The share price of the company, which went public on the New York Stock Exchange in 1997, is trading around $25.

  • Dawn Diaz is heading to Lancaster, Calif.-based Rexhall Industries Inc. as the company’s new CFO. Rexhall CEO William Rex appointed her to the post after Diaz had worked at the motor-home manufacturer as a consultant. “We have been impressed with Dawn’s efforts and believe that this will be a good fit,” Rex said in a statement.

Diaz, who earned a business degree from California State University Northridge, started out as an accounting at KPMG LLP. She joins Rexhall from Bertelsmann Services Inc., where she was vice president of finance.

  • Management at Holliston, Mass.-based Harvard Bioscience Inc. promoted Susan Luscinski to CFO. Luscinski will succeed Jim Warren, who plans to retire within the next year from the company, which sells products to drug-discovery companies.

    Luscinski has made her way up the corporate ladder at Bioscience. She has worked at the company for 16 years, most recently as vice president of finance and administration. The company credits her with helping to ensure financial due diligence in the company’s many acquisitions in the past five years.

    Meanwhile, departing CFO Warren plans to continue to help out with investor relations and consulting part-time.

    “Sue’s long experience with the company and extensive background in all financial areas provides a solid foundation as we move forward,” CEO Chane Graziano said in a statement.

4 Powerful Communication Strategies for Your Next Board Meeting